Join to View Full Profile
1120 15th StAugusta, GA 30912
Phone+1 706-721-8623
Fax+1 706-721-1459
Dr. Keruakous is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amany Keruakous is a healthcare provider specializing in Internal Medicine, with subspecialties in Hematology and Oncology, based in Augusta, GA. She completed her residency in Internal Medicine at the University of Toledo from 2015 to 2018, and is a graduate of the University of Alexandria Faculty of Medicine (Class of 2013). Dr. Keruakous has published multiple articles in renowned journals such as Hematology Reports, Hematology/Oncology and Stem Cell Therapy, Frontiers in Public Health, Bone Marrow Transplantation, and Cancers. Her work mostly revolves around leukemia, lymphoma, health care disparities, and molecular therapies like CAR T-cell therapy.
Education & Training
University of ToledoResidency, Internal Medicine, 2015 - 2018
University of Alexandria Faculty of MedicineClass of 2013
Certifications & Licensure
GA State Medical License 2021 - 2026
OK State Medical License 2018 - 2021
OH State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia.Marisol Miranda-Galvis, Kellen C Tjioe, Muhannad Sharara, McKenzie Maloney, Amany R Keruakous
Leukemia. 2025-09-11 - Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid.Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan
Mediterranean Journal of Hematology and Infectious Diseases. 2025-01-01 - 1 citationsAssessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/mversus 140 mg/m.Zachary Brown, Campbell Scott, Li Fang Zhang, Ramses Sadek, Andrea Clarke
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-01
Press Mentions
Clinical Challenges: FLT3 Inhibitors After Allo-Transplant in AMLJanuary 6th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
